Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study
Figure 1
Prediction of survival at 60 months for the AJCC 3rd and 6th Editions (top) and 30 months for the cases converted to the AJCC 7th Edition (bottom) for both lung adenocarcinoma (left) and squamous cell lung cancer (right) using ROC curves.
P<0.05 indicates that the full model is significantly more accurate in predicting disease-specific survival than tumor stage.